|
|
||||||||
Technical Briefs |
(TNF-
) -863C/A Promoter Polymorphism That Determines TNF-
Response
Departments of
1 Anesthesia,
4 Experimental Internal Medicine, and
5 Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Departments of
2 Clinical Chemistry and Pathobiochemistry,
3 Transfusion Medicine, and
6 Dermatology, University Hospital, Aachen, Germany
aaddress correspondence to this author at: Department of Anesthesia, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; fax 31-20-6979441, e-mail m.heesen@amc.uva.nl
| The first 300 words of the full text of this article appear below. |
Tumor necrosis factor-
(TNF-
) plays a central role in orchestrating the inflammatory response (1). Accordingly, blocking TNF-
activity has become a standard treatment of several inflammatory diseases (2)(3). TNF-
production shows high interindividual variations, which have been assigned mainly to inherited factors (4). Several genetic polymorphisms related to TNF-
synthesis have been detected in the TNF gene (5)(6). The -308 promoter polymorphism was found to affect TNF-
production by some authors (7) but not by others (8). Similar inconsistencies have been found for the association of this polymorphic site with susceptibility to and/or outcome of sepsis (8)(9). The NcoI polymorphism located within the first intron of the lymphotoxin A (LTA) gene was reported to be associated with TNF-
plasma concentrations (8). In a recent report, de Jong et al. (10) found no relationship between ex vivo TNF-
production on endotoxin stimulation of human whole blood and +489, -238, and -376 single-nucleotide polymorphisms or TNFa microsatellites of the TNF-
gene (10). Thus, the genetic factors determining the TNF-
response to infection are still poorly defined.
Recently, Skoog et al. (11) identified a C/A exchange at position -863 of the TNF-
gene promoter and found higher transcriptional activity of the C allele in reporter gene assays. This polymorphic site was found to be associated with thyroid-associated ophthalmopathy (12), Crohn disease(13), juvenile rheumatoid arthritis (14), and the lumbar spine area (15).
In the present study we sought to determine the association of the -863 TNF-
promoter polymorphism with the TNF-
production capacity of human blood cells. We describe a new real-time PCR assay with specific
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |